I27.21 – Secondary pulmonary arterial hypertension
Coding Notes
Active
Billable, valid for HIPAA-covered transactions
Applicable To
(Associated) (drug-induced) (toxin-induced) pulmonary arterial hypertension NOS
(Associated) (drug-induced) (toxin-induced) (secondary) group 1 pulmonary hypertension
Code Also
associated conditions if applicable, or adverse effects of drugs or toxins, such as:
adverse effect of appetite depressants (T50.5X5)
congenital heart disease (Q20-Q28)
human immunodeficiency virus [HIV] disease (B20)
polymyositis (M33.2-)
portal hypertension (K76.6)
rheumatoid arthritis (M05.-)
schistosomiasis (B65.-)
Sjögren syndrome (M35.0-)
systemic sclerosis (M34.-)
GEM Conversion to ICD-9 CM
Fs: 10000
–
Other chronic pulmonary heart diseases
MDC / MS-DRG Reference
Back Reference of Diagnostic Codes
Sibling Codes
Parent Sibling Codes
View in Tabular
| Code | Title |
|---|---|
| I00-I99 | Diseases of the circulatory system (I00-I99) |
| I26-I28 | Pulmonary heart disease and diseases of pulmonary circulation (I26-I28) |
| I27 | Other pulmonary heart diseases |
| I27.2 | Other secondary pulmonary hypertension |
| I27.21 |
Secondary pulmonary arterial hypertension
Applicable to
(Associated) (drug-induced) (toxin-induced) pulmonary arterial hypertension NOS
(Associated) (drug-induced) (toxin-induced) (secondary) group 1 pulmonary hypertension
Code Also
associated conditions if applicable, or adverse effects of drugs or toxins, such as:
adverse effect of appetite depressants (T50.5X5)
congenital heart disease (Q20-Q28)
human immunodeficiency virus [HIV] disease (B20)
polymyositis (M33.2-)
portal hypertension (K76.6)
rheumatoid arthritis (M05.-)
schistosomiasis (B65.-)
Sjögren syndrome (M35.0-)
systemic sclerosis (M34.-)
|